Kerri Fitzgerald

DocwireNews

Acute <a href="https://www.docwirenews.com/docwire-pick/nephrology-picks/donor-kidney-acceptance-practices-and-wait-listed-patients/">kidney injury</a> (AKI) is common in patients with cancer receiving checkpoint inhibitor therapy, according to a study published in the Clinical Journal of the American Society of Nephrology.Researchers included all patients (n=1,016; mean age, 63 years) who received checkpoint inhibitor therapy from May 2011 to December 2016 at Massachusetts General Hospital. Researchers compared baseline serum creatinine (from six months before therapy initiation; mean, 0.9 mg/dL) to creatinine measurements taken within 12 months of starting the therapy.<h2>AKI incidence with checkpoint inhibitor use</h2><a href="https://www.docwirenews.com/latest-nephrology-news/relationship-of-dietary-fiber-intake-to-inflammation-and-oxidative-stress-in-patients-on-hemodialysis/">AKI occurred</a> in 17% of the study population (n=169), and 8% experienced sustained AKI (n=82). Thirty patients (3%)&nbsp;had potential checkpoint inhibitor-related AKI.On average, the first episode of sustained AKI occurred 106 days after checkpoint inhibitor initiation. Sixteen patients (2%) experienced stage 3 sustained AKI, and four patients required dialysis.Proton pump inhibitor use at baseline was associated with sustained AKI. Two-thirds of patients (67%) with sustained AKI died during follow-up (mean time to death, 22 days after episode).

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Jordana Jampel

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Eric Bergson, MD

Rob Dillard

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Latest News

Acute Kidney Injury Common in Those Who Receive Checkpoint Inhibitors

Acute Kidney Injury

Acute kidney injury (AKI) is common in patients with cancer receiving checkpoint inhibitor therapy, according to a study published in the Clinical Journal of the American ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe